European recommendations for short-term surveillance of health problems in childhood, adolescent and young adult cancer survivors from the end of treatment to 5 years after diagnosis: a PanCare guideline.
Aftercare
Cancer survivors
Paediatric oncology
Practice guideline
Quality of life
Short-term follow-up care
Surveillance
Survivorship
Survivorship Passport
Journal
Journal of cancer survivorship : research and practice
ISSN: 1932-2267
Titre abrégé: J Cancer Surviv
Pays: United States
ID NLM: 101307557
Informations de publication
Date de publication:
04 Dec 2023
04 Dec 2023
Historique:
received:
27
09
2023
accepted:
27
10
2023
medline:
4
12
2023
pubmed:
4
12
2023
entrez:
4
12
2023
Statut:
aheadofprint
Résumé
Childhood, adolescent and young adult (CAYA) cancer survivors require ongoing surveillance for health problems from the end of cancer treatment throughout their lives. There is a lack of evidence-based guidelines on optimal surveillance strategies for the period from the end of treatment to 5 years after diagnosis. We aimed to address this gap by developing recommendations for short-term surveillance of health problems based on existing long-term follow-up (LTFU) care guidelines. The guideline working group, consisting of healthcare professionals, parents and survivor representatives from 10 countries, worked together to identify relevant health problems that may occur in survivors between the end of treatment and 5 years after diagnosis and to develop recommendations for short-term surveillance of health problems. The recommendations were drawn from existing LTFU guidelines and adapted where necessary based on clinical expertise. The working group developed 44 recommendations for short-term surveillance of health problems, which were divided into four categories based on the level of surveillance required: awareness only (n = 11), awareness, history and/or physical examination without surveillance test (n = 15), awareness, history and/or physical examination with potential surveillance test (n = 1) and awareness, history and/or physical examination with surveillance test (n = 17). The development of a guideline for short-term surveillance of health problems fills a critical gap in survivorship care for CAYA cancer survivors, providing much-needed support immediately after treatment up to 5 years after diagnosis. This guideline will support healthcare professionals to provide appropriate follow-up care and improve the quality of life of CAYA cancer survivors.
Identifiants
pubmed: 38048011
doi: 10.1007/s11764-023-01493-z
pii: 10.1007/s11764-023-01493-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Organisme : Horizon 2020
ID : 899999
Investigateurs
Desiree Grabow
(D)
Anna-Liesa Filbert
(AL)
Dorothea Niehoff
(D)
Diana Walz
(D)
Friederike Erdmann
(F)
Claudia Spix
(C)
Riccardo Haupt
(R)
Monica Muraca
(M)
Simone Lightwood
(S)
Francesca Bagnasco
(F)
Giacomo Cavalca
(G)
Sara Oberti
(S)
Brigitte Nicolas
(B)
Ruth Ladenstein
(R)
Edit Bardi
(E)
Vanessa Düster
(V)
Anne Uyttebroeck
(A)
Maria van Helvoirt
(M)
Jurgen Lemiere
(J)
Marleen Renard
(M)
An Michiels
(A)
Thorsten Langer
(T)
Ann-Kristin Kock-Schoppenhauer
(AK)
Lea Hildebrand
(L)
Anke Neumann Anne-Katrin Jahnke
(ANA)
Jelena Rascon
(J)
Justas Trinkūnas
(J)
Audronė Ciesiūnienė
(A)
Paulius Ragauskas
(P)
Adela Cañete Nieto
(AC)
Julia Balaguer Guill
(JB)
Maria Teresa Tormo Alcañiz
(MTT)
Antonio Orduña Galan
(AO)
Marisa Correcher Palau
(MC)
Lucas Cervero Beltrán
(LC)
Vicente Pons Tamarit
(VP)
Davide Saraceno
(D)
Alessandra Berti
(A)
Carlo Contino
(C)
Nikos Thomopulos
(N)
Giulia Stabile
(G)
Maria Franca Tomassi
(MF)
Igor Zamberlan
(I)
Barbara Nichel
(B)
Günter Schreier
(G)
Dieter Hayn
(D)
Karl Kreiner
(K)
Stefan Beyer
(S)
Catherine Chronaki
(C)
Giorgio Cangioli
(G)
Eliana Charalambous
(E)
Alexander Degelsegger-Márquez
(A)
Gerald Gredinger
(G)
Kathrin Trunner
(K)
Florian Trauner
(F)
Anja Laschkolnig
(A)
Leontien Kremer
(L)
Heleen van der Pal
(H)
Saskia Pluijm
(S)
Selina van den Oever
(S)
Ismay de Beijer
(I)
Jessica Trollip
(J)
Emma Hardijzer
(E)
Heleen van der Pal
(H)
Jaap den Hartogh
(JD)
Jeroen Te Dorsthorst
(JT)
Samira Essiaf
(S)
William Sciberras
(W)
Anita Kienesberger
(A)
Hannah Gsell
(H)
Carina Schneider
(C)
Zuzana Tomasikova
(Z)
Informations de copyright
© 2023. The Author(s).
Références
World Health Organization. Childhood cancer. (2021) Accessed on 10 August 2022 from; https://www.who.int/news-room/fact-sheets/detail/cancer-in-children
Francisci S, Guzzinati S, Dal Maso L, Sacerdote C, Buzzoni C, Gigli A. An estimate of the number of people in Italy living after childhood cancer. Int J Cancer. 2017;140(11):2444–50. https://doi.org/10.1002/ijc.30665 .
doi: 10.1002/ijc.30665
pubmed: 28233308
Hjorth L, Haupt R, Skinner R, Grabow D, Byrne J, Karner S, Network PanCare, et al. Survivorship after childhood cancer: PanCare: a European Network to promote optimal long-term care. Eur J Cancer. 2015;51(10):1203–11. https://doi.org/10.1016/j.ejca.2015.04.002 .
doi: 10.1016/j.ejca.2015.04.002
pubmed: 25958037
pmcid: 5916870
Geenen MM, Cardous-Ubbink MC, Kremer LCM, Van den Bos C, Van der Pal HJH, Heinen RC, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA. 2007;297(24):2705. https://doi.org/10.1001/jama.297.24.2705 .
doi: 10.1001/jama.297.24.2705
pubmed: 17595271
Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82. https://doi.org/10.1056/nejmsa060185 .
doi: 10.1056/nejmsa060185
pubmed: 17035650
Hudson MM, Mertens AC, Yasui Y, Hobbie W, Chen H, Gurney JG, Childhood Cancer Survivor Study Investigators. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003;290(12):1583–92. https://doi.org/10.1001/jama.290.12.1583 .
doi: 10.1001/jama.290.12.1583
pubmed: 14506117
Alberts NM, Gagnon MM, Stinson JN. Chronic pain in survivors of childhood cancer: a developmental model of pain across the cancer trajectory. Pain. 2018;159(10):1916–27. https://doi.org/10.1097/j.pain.0000000000001261 .
doi: 10.1097/j.pain.0000000000001261
pubmed: 29708940
Mulrooney DA, Yeazel MW, Kawashima T, Mertens AC, Mitby P, Stovall M, Leisenring WM. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ. 2009;339:b4606. https://doi.org/10.1136/bmj.b4606 .
doi: 10.1136/bmj.b4606
pubmed: 19996459
pmcid: 3266843
Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Robison LL. Fertility of female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27(16):2677–85. https://doi.org/10.1200/JCO.2008.20.1541 .
doi: 10.1200/JCO.2008.20.1541
pubmed: 19364965
pmcid: 2690392
Green DM, Kawashima T, Stovall M, Leisenring W, Sklar CA, Mertens AC, Robison LL. Fertility of male survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Onco. 2010;28(2):332–9. https://doi.org/10.1200/JCO.2009.24.9037 .
doi: 10.1200/JCO.2009.24.9037
Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJH, Kremer LCM. Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER study cohort: role of chemotherapy. J Clin Oncol. 2017;35(20):2288–98.
doi: 10.1200/JCO.2016.71.6902
pubmed: 28530852
Streefkerk N, Tissing WJE, Korevaar JC, van der Pal HJH, Besselink NJM, Versluys AB, Kremer LCM. A detailed insight in the high risks of hospitalizations in long-term childhood cancer survivors- a Dutch LATER linkage study. PloS one. 2020;15(5):e0232708. https://doi.org/10.1371/journal.pone.0232708 .
doi: 10.1371/journal.pone.0232708
pubmed: 32427994
pmcid: 7236987
Van Deuren S, Penson A, Van Dulmen-den Broeder E, Streefkerk N, Van Der Pal HJ, Blijlevens N, Kremer LC. Prevalence and risk factors of cancer-related fatigue in childhood cancer survivors: a DCCSS LATER study. Cancer. 2022;128(5):1110–21. https://doi.org/10.1002/cncr.33993 .
doi: 10.1002/cncr.33993
pubmed: 34724201
Van Erp LME, Maurice-Stam H, Kremer LCM, Van Der Pal HJH, Loonen JJ, Tissing WJE. A vulnerable age group: the impact of cancer on the psychosocial well-being of young adult childhood cancer survivors. Support Care Cancer. 2021;29(8):4751–61. https://doi.org/10.1007/s00520-021-06009-y .
doi: 10.1007/s00520-021-06009-y
pubmed: 33527229
pmcid: 8236461
Verbruggen LC, Kok JL, Teepen JC, Van Der Pal HJ, Biesma DH, Van Den Berg H, Kremer LC. Clinical characteristics of subsequent histologically confirmed meningiomas in long-term childhood cancer survivors: a Dutch LATER study. Europ J Cancer. 2021;150:240–9. https://doi.org/10.1016/j.ejca.2021.03.021 .
doi: 10.1016/j.ejca.2021.03.021
Oeffinger KC, Hudson MM, Landier W. Survivorship: childhood cancer survivors. Prim Care: Clin Off Prac. 2009;36(4):743–80. https://doi.org/10.1016/j.pop.2009.07.007 .
doi: 10.1016/j.pop.2009.07.007
Heirs M, Suekarran S, Slack R, Light K, Gibson F, Glaser A, Hawkins M, Phillips R. A systematic review of models of care for the follow-up of childhood cancer survivors. Pediatr Blood Cancer. 2012;60(3):351–6. https://doi.org/10.1002/pbc.24253 .
doi: 10.1002/pbc.24253
pubmed: 22848011
Michel G, Mulder RL, Van der Pal HJH, Skinner R, Bárdi E, Brown MC, et al. Evidence-based recommendations for the organization of long-term follow-up care for childhood and adolescent cancer survivors: a report from the PanCareSurFup Guidelines Working Group. J Cancer Surviv. 2019;13(5):759–72. https://doi.org/10.1007/s11764-019-00795-5 .
doi: 10.1007/s11764-019-00795-5
pubmed: 31396878
Kremer LC, Mulder RL, Oeffinger KC, Bhatia S, Landier W, Levitt G, Hudson MM. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Pediatr Blood Cancer. 2013;60(4):543–9. https://doi.org/10.1002/pbc.24445 .
doi: 10.1002/pbc.24445
pubmed: 23281199
Mulder RL, Hudson MM, Bhatia S, Landier W, Levitt G, Constine SL, Oeffinger KC. Updated breast cancer surveillance recommendations for female childhood, adolescent and young adult cancer survivors from the International Guideline Harmonization Group. J Clin Oncol. 2020;38(35):4194–207. https://doi.org/10.1200/JCO.20.00562 .
doi: 10.1200/JCO.20.00562
pubmed: 33078972
pmcid: 7723685
Ehrhardt MJ, Leerink JM, Mulder RL, Mavinkurve-Groothuis A, Kok W, Nohria A, Armenian SH. Systematic review and updated recommendations for cardiomyopathy surveillance for survivors of childhood, adolescent, and young adult cancer from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2023;24(3):E108–20. https://doi.org/10.1016/S1470-2045(23)00012-8 .
doi: 10.1016/S1470-2045(23)00012-8
pubmed: 37052966
van Dorp W, Mulder RL, Kremer LC, Hudson MM, Van den Heuvel-Eibrink MM, Van den Berg MH, Haupt R. Recommendations for premature ovarian insufficiency surveillance for female childhood, adolescent and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. J Clin Oncol. 2016;34(28):3440–50. https://doi.org/10.1200/JCO.2015.64.3288 .
doi: 10.1200/JCO.2015.64.3288
pubmed: 27458300
pmcid: 5569686
Skinner R, Mulder RL, Kremer LC, Hudson MM, Constine LS, Bardi E, Green DM. Recommendations for gonadotoxicity surveillance in male childhood, adolescent and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Lancet Oncol. 2017;18(2):e75–90. https://doi.org/10.1016/S1470-2045(17)30026-8 .
doi: 10.1016/S1470-2045(17)30026-8
pubmed: 28214419
Clement SC, Kremer LCM, Verburg FA, Simmons JH, Goldfarb M, Peeters RP, van Santen HM. Balancing the benefits and harms of thyroid cancer surveillance in survivors of childhood, adolescent and young adult cancer: recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium. Cancer Treat Rev. 2018;63:28–39. https://doi.org/10.1016/j.ctrv.2017.11.005 .
doi: 10.1016/j.ctrv.2017.11.005
pubmed: 29202445
Clemens E, van den Heuvel-Eibrink MM, Mulder RL, Kremer LCM, Hudson MM, Skinner R, Landier W. International Guideline Harmonization Group ototoxicity group. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium. Lancet Oncol. 2019;20:e29–41. https://doi.org/10.1016/S1470-2045(18)30858-1 .
doi: 10.1016/S1470-2045(18)30858-1
pubmed: 30614474
pmcid: 7549756
van der Kooi ALF, Mulder RL, Hudson MM, Kremer LCM, Skinner R, Constine LS, van den Heuvel-Eibrink MM. Counseling and surveillance of obstetrical risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Amer J Obstet Gynecol. 2020;S0002–9378(20):30614–1. https://doi.org/10.1016/j.ajog.2020.05.058 .
doi: 10.1016/j.ajog.2020.05.058
Bowers DC, Verbruggen LC, Kremer LCM, Hudson MM, Skinner R, Constine LS, Mulder RL. Surveillance for subsequent neoplasms of the CNS for childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021;22:e196–206. https://doi.org/10.1016/S1470-2045(20)30688-4 .
doi: 10.1016/S1470-2045(20)30688-4
pubmed: 33845037
Christen S, Roser K, Mulder RL, Ilic A, Lie HC, Loonen JJ, Michel G. IGHG psychological late effects group. Recommendations for the surveillance of cancer-related fatigue in childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. J Cancer Survivors. 2020;14:923–38. https://doi.org/10.1007/s11764-020-00904-9 .
doi: 10.1007/s11764-020-00904-9
Devine KA, Christen S, Mulder RL, Brown MC, Ingerski LM, Mader L, Schulte F, on behalf of the IGHG psychological late effects group. Recommendations for the surveillance of education and employment outcomes in survivors of childhood, adolescent and young adult cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Cancer. 2022;128(13):2405–19. https://doi.org/10.1002/cncr.34215 .
doi: 10.1002/cncr.34215
pubmed: 35435238
GillelandMarchak J, Christen S, Mulder RL, Baust K, Blom JMC, Brinkman TM, Michel G, on behalf of the IGHG psychological late effects group. Recommendations for the surveillance of mental health problems in childhood, adolescent and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group (2022). Lancet Oncol. 2022;23:e184-96. https://doi.org/10.1016/S1470-2045(21)00750-6 .
doi: 10.1016/S1470-2045(21)00750-6
van Dalen EC, Mulder RL, Suh E, Ehrhardt MJ, Aune GJ, Bardi E, Mulrooney DA. Coronary artery disease surveillance among childhood, adolescent, and young adult cancer survivors: a systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Europ J Cancer. 2021;156:127–37. https://doi.org/10.1016/j.ejca.2021.06.021 .
doi: 10.1016/j.ejca.2021.06.021
Mulder RL, Font-Gonzalez A, Hudson MM, van Santen HM, Loeffen EAH, Burns KC, Tissing WJE, on behalf of the PanCareLIFE Consortium. Fertility preservation for female childhood, adolescent, and young adult patients with cancer: recommendations from the PanCareLIFE consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021;22:e45–56. https://doi.org/10.1016/S1470-2045(20)30594-5 .
doi: 10.1016/S1470-2045(20)30594-5
pubmed: 33539753
Mulder RL, Font-Gonzalez A, Green DM, Loeffen EAH, Hudson MM, Loonen JJ, van de Wetering MD, on behalf of the PanCareLIFE Consortium. Fertility preservation for male childhood, adolescent and young adult patients with cancer: recommendations from the PanCareLIFE consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021;22:e57–67. https://doi.org/10.1016/S1470-2045(20)30582-9 .
doi: 10.1016/S1470-2045(20)30582-9
pubmed: 33539754
Mulder RL, Font-Gonzalez A, van Dulmen-den Broeder E, Quinn GP, Ginsberg JP, Loeffen EAH, Inthorn J, on behalf of the PanCareLIFE Consortium. Communication and ethical considerations for fertility preservation for childhood, adolescent, and young adult patients with cancer: recommendations from the PanCareLIFE consortium and the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2021;22:e68–80. https://doi.org/10.1016/S1470-2045(20)30595-7 .
doi: 10.1016/S1470-2045(20)30595-7
pubmed: 33539755
Van Atteveld JE, Mulder RL, van den Heuvel-Eibrink MM, Hudson MM, Kremer LCM, Skinner R, Di Iorgi N. Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Diabetes Endocrinol. 2021;9:622–37. https://doi.org/10.1016/S2213-8587(21)00173-X .
doi: 10.1016/S2213-8587(21)00173-X
pubmed: 34339631
pmcid: 8744935
Bardi E, Mulder RL, van Dalen EC, Bhatt NS, Ruble KA, Burgis J, Bresters D. Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: recommendations from the international late effects of childhood cancer guideline harmonization group. Cancer Treatt Rev. 2021;100:102296. https://doi.org/10.1016/j.ctrv.2021.102296 .
doi: 10.1016/j.ctrv.2021.102296
van Iersel L, Mulder RL, Denzer C, Cohen LE, Spoudeas HA, Meacham LR, van Santen HM. Hypothalamic-pituitary and other endocrine surveillance among childhood cancer survivors. Endocr Rev. 2022;43(5):794–823. https://doi.org/10.1210/endrev/bnab040 .
doi: 10.1210/endrev/bnab040
pubmed: 34962573
van Kalsbeek RJ, van der Pal HJ, Kremer LC, Bardi E, Brown MC, Effeney R, Mulder RL. European PanCareFollowUp recommendations for surveillance of late effects of childhood, adolescent, and young adult cancer. Europ J Cancer. 2021;154:316–28. https://doi.org/10.1016/j.ejca.2021.06.004 .
doi: 10.1016/j.ejca.2021.06.004
Haupt R, Essiaf S, Dellacasa C, Ronckers CM, Caruso S, Sugden E, et al. The ‘Survivorship Passport’ for childhood cancer survivors. Eur J Cancer. 2018;102:69–81. https://doi.org/10.1016/j.ejca.2018.07.006 .
doi: 10.1016/j.ejca.2018.07.006
pubmed: 30138773
Loonen JJ, Blijlevens NM, Prins J, et al. Cancer survivorship care: person centered care in a multidisciplinary shared care model. Int J Integr Care. 2018;18(1):4. https://doi.org/10.5334/ijic.3046
Kaal SE, Husson O, van Duivenboden S, Jansen R, Manten-Horst E, Servaes P, van der Graaf WT. Empowerment in adolescents and young adults with cancer: relationship with health-related quality of life. Cancer. 2017;123(20):4039–47. https://doi.org/10.1002/cncr.30827 .
doi: 10.1002/cncr.30827
pubmed: 28696580
Feijen EAM, Leisenring WM, Stratton KL, et al. Derivation of anthracycline and anthraquinone equivalence ratios to doxorubicin for late-onset cardiotoxicity. JAMA Oncol. 2019;5(6):864–71.
doi: 10.1001/jamaoncol.2018.6634
pubmed: 30703192
pmcid: 6490232
Feijen EAM, Font-Gonzalez A, van der Pal HJH, et al. Risk and temporal changes of heart failure among 5-year childhood cancer survivors: a DCOG-LATER study. J Am Heart Assoc. 2019;8(1):e009122.
doi: 10.1161/JAHA.118.009122
pubmed: 30595059